Online Pharmacy Training

U.S. Food and Drug Administration (FDA) has approved the dermal filler, Bellafill- polymethylmethacrylate (PMMA) collagen filler - for the treatment of skin condition scars. Bellafill represents a big clinical advancement because the solely filler on the market approved for this disfiguring skin condition. skin condition is that the commonest skin condition within the U.S., poignant 40-50 million people1 and up to ninety fifth of individuals with skin condition could endure to suffer from scarring.  Bellafill was studied extensively before its office approval and established to be safe and effective for the correction of moderate to severe, atrophic, expansive facial skin condition scars on the cheek in patients over the age of twenty one years.

FDA approved Lynparza for treatment of Advanced Ovarian Cancer The U.S. Food and Drug Administration nowadays granted accelerated approval to Lynparza (olaparib), a brand new drug treatment for ladies with advanced ovarian cancer related to defective BRCA genes, as detected by associate degree FDA-approved take a look at. Ovarian cancer forms within the ovary, one in all a try of feminine reproductive glands wherever ova, or eggs, are formed. The National Cancer Institute estimates that 21,980 american girls are going to be diagnosed with and 14,270 can die from ovarian cancer in 2014. Lynparza is a poly ADP-ribose enzyme (PARP) substance that blocks enzymes concerned in repairing broken DNA. it's meant for ladies with heavily pretreated gonad cancer that's related to defective BRCA genes. “Today’s approval constitutes the primary of a brand new category of medication for treating gonad cancer,” same Richard Pazdur, MD, director of the workplace of haematology and medicin...

The US Food and Drug Administration ( FDA ) has approved Natesto (testosterone),  once  CompleoTRT™,  the primary  and  solely  androgen  nasal gel for replacement  medical aid  in adult males for conditions  related to  a deficiency or absence of endogenous  androgen . Natesto is self-administered via a nasal  applier  thereby minimizing  the chance  of secondary exposure to  androgen   of girls  or  youngsters .

CRE, which stands for carbapenem-resistant Enterobacteriaceae, are a family of germs that are difficult to treat because they have high levels of resistance to antibiotics. 

 A review of past research finds that fever-reducing drugs have no effect on the speed of children's recovery from an infection, contrary to the fears of some doctors and parents. Researchers have debated for decades whether lowering a sick child's fever helps the recovery process or interferes with the body's ability to fight the infection. Some previous research has shown that giving children fever-reducing "antipyretic" medications, such as acetaminophen, after vaccinations interfered with their immune responses to the vaccines, for example.

THURSDAY May 16, 2013 -- An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.

Clinical Context Tadalafil is a phosphodiesterase-5 (PDE5) inhibitor that was approved by the US Food and Drug Administration (FDA) in 2003 to treat erectile dysfunction (ED). The FDA has now expanded the approved indications to include benign prostatic hyperplasia (BPH), either alone or in combination with ED.

A new set of evidence-based guidelines provides an algorithm for reducing colchicine doses to prevent toxicity in patients who are also taking drugs such as cyclosporine, ketoconazole, ritonavir, clarithromycin, azithromycin, verapamil extended release (ER), or diltiazem ER. The research group was led by Robert A. Terkeltaub, MD, from the Veterans Administration San Diego Medical Center in California, and the new report appears in the August issue of Arthritis & Rheumatism .

WEDNESDAY, July 20 -- Inherited forms of Alzheimer's disease may be detectable up to two decades before problems with memory and thinking develop, according to new research. The findings are significant because by the time dementia symptoms appear, the disease has severely damaged the brain, making it nearly impossible to restore a patient's mental abilities or memories, the study authors noted.

BATH, United Kingdom & BRISTOL, United Kingdom & SEATTLE--(BUSINESS WIRE)--Jul 14, 2011 - A pioneering method for fighting burn infections in children using viruses which ˜eat' disease-causing bacteria has been awarded new funding. It is hoped the project will develop a burns dressing that will prevent and treat ˜superbugs' that have become resistant to antibiotics – without the use of antibiotics or synthetic antimicrobials. Scientists from Bristol's Frenchay hospital, the University of Bath and AmpliPhi Biosciences (Pink Sheets: APHB) in Bedfordshire are harnessing bacteriophages - viruses which kill bacteria.

An  E. coli  outbreak in Europe claimed two more lives in recent days, bringing to 16 the total number of deaths attributed to tainted vegetables in Germany, officials reported Tuesday.

The U.S. Food and Drug Administration has approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency. Patients with congenital Factor XIII deficiency don't make enough Factor XIII, a substance that circulates in the blood and is important for normal clotting. Without treatment, people with the condition are at risk for life-threatening bleeding.

Aspirin 's ability to prevent potentially deadly blood clots may be hindered by elevated levels of fatty acids in the bloodstream, a new study suggests. It's common for doctors to prescribe aspirin as a blood thinner for patients at high risk of a heart attack. Aspirin inhibits the activity of the COX-1 enzyme, which plays a role in blood clot formation. It's known that free fatty acids -- released into the bloodstream during the breakdown of fat cells -- also inhibit COX-1 activity.

The U.S. Food and Drug Administration (FDA) has approved Duexis (ibuprofen/famotidine), a novel tablet formulation containing a fixed-dose combination of ibuprofen (800 mg) and famotidine (26.6 mg). The FDA approval was supported by data from the pivotal REDUCE-1 and REDUCE-2 studies, which showed patients taking Duexis experienced significantly fewer upper gastrointestinal ulcers compared to patients receiving ibuprofen alone.

Death and serious adverse reactions, including increased heart rate, transient hyperglycemia, hypokalemia, cardiac arrhythmias, pulmonary edema, and myocardial ischemia have been reported after prolonged administration of oral or injectable terbutaline to pregnant women.

An injection of local anesthetic can be made much less painful if it is warmed beforehand, Canadian researchers report.

By the time you read this, the Vaccine = Autism published by the BJM will be old news (Yes, I do write a bunch of rants at once and have them post at a later date). However lets take a closer look at this whole situation. The Angry Pharmacist » Blog Archive » Vaccines, Autism, and Dipshit Jenny McCarthy :

 Babies who were formula-fed and introduced to solid foods before they were 4 months old were more likely to be obese when they were 3, researchers report.

Preeclampsia occurs when a pregnant woman's blood pressure spikes rapidly. It can lead to stroke, organ failure and other life-threatening conditions in both the mother and baby. The American Congress of Obstetricians and Gynecologists says possible warning signs of preeclampsia include: Headaches. Vision abnormalities. Quickly gaining weight. Swollen face and hands.

FRIDAY, Feb. 4 -- The U.S. Food and Drug Administration has approved the first drug to help prevent premature birth in women who have had at least one previous preterm delivery. The drug -- called Makena (hydroxyprogesterone caproate) -- is expected to reduce the risk of premature delivery, which experts say raises the risk of infant complications at birth, lifelong disabilities such as cerebral palsy, and even death. Preterm delivery is a serious problem in the United States, FDA spokeswoman Shelly Burgess said.